Literature DB >> 29542018

Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury.

Jia-Bo Wang1, Yun Zhu1, Zhao-Fang Bai1, Fu-Sheng Wang2, Xiu-Hui Li3, Xiao-He Xiao4.   

Abstract

Herb-induced liver injury (HILI) is a type of adverse drug reactions related to using Chinese medicine (CM) or herbal medicine (HM), and is now a growing segment of drug-induced liver injury (DILI) worldwide. Owing to the complicated compositions and miscellaneous risk factors associated with the clinical usage of CM or HM, it is more challenging to diagnose and manage HILI than DILI. In the present guideline issued by the China Association of Chinese Medicine (CACM), the authors present an evidence chain-based workflow with 9 structured judgment criteria for diagnosing HILI. The 3 diagnostic ending points-suspected diagnosis, clinical diagnosis, and confirmed diagnosis-could be reached according to the length of the evidence chain acquired in the structured diagnostic workflow. Either identifying the species of CM or HM or excluding adulterations and toxin contaminants was strongly recommended to improve the level of evidence for a clinical diagnosis of HILI. In addition, the authors report that the improper use of CM, which violates the general law of CM theory, is one of the most important factors that contributes to HILI and should be avoided. By contrast, based on syndrome differentiation, some CM can also be used to treat HILI if used in accordance with the general law of CM theory. Therefore, 9 recommendations are put forward in this guideline.

Entities:  

Keywords:  Chinese medicine; diagnosis; guideline; herb-induced liver injury; management; treatment

Mesh:

Substances:

Year:  2018        PMID: 29542018     DOI: 10.1007/s11655-018-3000-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   2.626


  29 in total

Review 1.  Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review.

Authors:  E Ernst
Journal:  J Intern Med       Date:  2002-08       Impact factor: 8.989

2.  [Chinese herb and drug-induced liver injury].

Authors:  Yi-yang Hu; Fu Huang
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2012-03

3.  Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum.

Authors:  Jiabo Wang; Zhijie Ma; Ming Niu; Yun Zhu; Qingsheng Liang; Yanling Zhao; Jingyuan Song; Zhaofang Bai; Yaming Zhang; Ping Zhang; Na Li; Yakun Meng; Qi Li; Lushan Qin; Guangju Teng; Junling Cao; Baosen Li; Shilin Chen; Yonggang Li; Zhengsheng Zou; Honghao Zhou; Xiaohe Xiao
Journal:  Front Med       Date:  2015-10-12       Impact factor: 4.592

4.  ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.

Authors:  Naga P Chalasani; Paul H Hayashi; Herbert L Bonkovsky; Victor J Navarro; William M Lee; Robert J Fontana
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

5.  [Comparison of processed and crude Polygoni Multiflori Radix induced rat liver injury and screening for sensitive indicators].

Authors:  Can Tu; Bing-qian Jiang; Yan-ling Zhao; Chun-yu Li; Na Li; Xiao-fei Li; Ge-liu-chang Jia; Jing-yao Pang; Zhi-jie Ma; Jia-bo Wang; Xiao-he Xiao
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2015-02

Review 6.  Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.

Authors:  Ge Lin; Ji Yao Wang; Na Li; Mi Li; Hong Gao; Yuan Ji; Fan Zhang; Huali Wang; Yan Zhou; Yang Ye; Hong Xi Xu; Jiang Zheng
Journal:  J Hepatol       Date:  2010-09-22       Impact factor: 25.083

7.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

8.  [Analysis of Clinical Characteristics in 595 Patients with Herb-induced Liver Injury].

Authors:  Yun Zhu; Yong-gang Li; Yao Wang; Li-ping Wang; Jia-bo Wang; Rui-lin Wang; Li-fu Wang; Ya-kun Meng; Zhong-xia Wang; He Xiao Xiao
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2016-01

9.  Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

Authors:  Naga Chalasani; Herbert L Bonkovsky; Robert Fontana; William Lee; Andrew Stolz; Jayant Talwalkar; K Rajendar Reddy; Paul B Watkins; Victor Navarro; Huiman Barnhart; Jiezhun Gu; Jose Serrano
Journal:  Gastroenterology       Date:  2015-03-06       Impact factor: 22.682

10.  Spontaneously reported hepatic adverse drug events in Korea: multicenter study.

Authors:  Hee Kwon; Suk-Hyang Lee; Seong-Eun Kim; Jae-Hyun Lee; Yung-Koo Jee; Hye-Ryun Kang; Byung-Joo Park; Jung-Won Park; Chein-Soo Hong
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

View more
  12 in total

Review 1.  Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Front Pharmacol       Date:  2019-10-24       Impact factor: 5.810

Review 2.  Drug-Induced Liver Injury: Highlights of the Recent Literature.

Authors:  Mark Real; Michele S Barnhill; Cory Higley; Jessica Rosenberg; James H Lewis
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

3.  Author Response to Letters on the Manuscript "Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series".

Authors:  Aabha Nagral; Omkar S Rudra; Kunal Adhyaru; Amit Gharat; Sonal Bhandare
Journal:  J Clin Exp Hepatol       Date:  2021-10-05

4.  Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration.

Authors:  Xiaohe Xiao; Jianyuan Tang; Yimin Mao; Xiuhui Li; Jiabo Wang; Chenghai Liu; Kewei Sun; Yong'an Ye; Zhengsheng Zou; Cheng Peng; Ling Yang; Yuming Guo; Zhaofang Bai; Tingting He; Jing Jing; Fengyi Li; Na An
Journal:  Acta Pharm Sin B       Date:  2018-12-14       Impact factor: 11.413

Review 5.  Complementary and Alternative Medicine-related Drug-induced Liver Injury in Asia.

Authors:  Cyriac Abby Philips; Philip Augustine; Sasidharan Rajesh; Praveen Kumar Y; Deepak Madhu
Journal:  J Clin Transl Hepatol       Date:  2019-09-02

6.  Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to Artemisia annua Tea.

Authors:  Francisco Javier Ruperti-Repilado; Simon Haefliger; Sophia Rehm; Markus Zweier; Katharina M Rentsch; Johannes Blum; Alexander Jetter; Markus Heim; Anne Leuppi-Taegtmeyer; Luigi Terracciano; Christine Bernsmeier
Journal:  Front Med (Lausanne)       Date:  2019-10-11

7.  Literature Review of Traditional Chinese Medicine Herbs-Induced Liver Injury From an Oncological Perspective With RUCAM.

Authors:  Hei Ching Chow; Tsz Him So; Horace Cheuk Wai Choi; Ka On Lam
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

8.  Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase.

Authors:  Florence van Hunsel; Sonja van de Koppel; Souad Skalli; Andrea Kuemmerle; Lida Teng; Jia-Bo Wang; Joanne Barnes
Journal:  Front Pharmacol       Date:  2019-11-06       Impact factor: 5.810

Review 9.  Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support.

Authors:  Rolf Teschke; Axel Eickhoff; Amy C Brown; Manuela G Neuman; Johannes Schulze
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

10.  Herb-induced liver injury: Systematic review and meta-analysis.

Authors:  Vinícius Remus Ballotin; Lucas Goldmann Bigarella; Ajacio Bandeira de Mello Brandão; Raul Angelo Balbinot; Silvana Sartori Balbinot; Jonathan Soldera
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.